Brett Brodnax, president and CEO of Dallas-based United Surgical Partners International, will retire at the end of 2023 and is expected to be replaced by Andy Johnston.
A growing interest in ASCs from health systems, the expansion of less common specialties, and the increased use of robots are three trends ASCs should keep an eye on in 2023.
The FDA has approved the use of tucatinib — a drug engineered by biotech company Seagen — in tandem with trastuzumab as a second-line treatment for colorectal cancer that has not responded to other therapies.
Shahzad Mian, MD, has been appointed interim chair of the department of ophthalmology and visual sciences at the Michigan Medicine medical school in Ann Arbor, effective Jan. 15.
A former Sears department store in Ontario, Ohio, will open as a medical office building by the end of January, according to a Jan. 20 report from Mansfield News Journal.
Horizon Equities has acquired a 10-property retail and medical office portfolio in Ocean County, N.J., for $46 million, according to a Jan. 20 report from Commercial Property Executive.